EAAT2 dysfunction leads to extracellular glutamate accumulation and is associated with many neurodegenerative diseases, like Huntington’s disease [49], Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotrophic multiple sclerosis (AMS) [39,49]. Here, SLC1A2 is linked to early-onset autosomal dominant Alzheimer disease.